#COVID #COVID19 #Britain

Britain has granted a conditional authorisation to Merck’s molnupiravir, which is the first pill shown to successfully treat Covid-19.

Britain has become the first country to clear the treatment, although it was not immediately clear how quickly the pill would be available. Molnupiravir is also pending review at regulators in the US, the European Union and elsewhere. 

The pill was licensed for adults 18 and older who have tested positive for Covid-19 and have at least one risk factor for developing severe disease, such as obesity or heart disease.

Molnupiravir, is intended to be taken twice a day for five days by people at home with mild to moderate Covid-19.

An antiviral pill that reduces symptoms and speeds recovery could prove groundbreaking, easing caseloads on hospitals and helping to curb outbreaks in poorer countries with fragile health systems.

It would also bolster the two-pronged approach to the pandemic: treatment, by way of medication, and prevention, primarily through vaccinations.

#COVID #CovidVaccine #Covidvax #covidmedicine #covidcure #covidprecaution #covidcases #britain #covidpill #coronavirus #china
#india #covaxin #covishield

Covid-19 Advice: Simple ways to manage dry or wet cough while recovering
[ Ссылка ]

Getting vaccinated? Here’s what to eat before and after your Covid-19 jab
[ Ссылка ]

COVID-19 brain fog: Here's how you can deal with it
[ Ссылка ]


For more videos, subscribe to our channel: www.youtube.com/c/editorji
Check out the editorji website for more news: www.editorji.com

To stay updated, download the editorji App: www.editorji.com/download

Follow editorji here:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Telegram: [ Ссылка ]

--------------------------------------------------------------------------------------------

свернуть